142 related articles for article (PubMed ID: 7786789)
1. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study.
Ma SK; Wong KF; Chan JK; Kwong YL
Br J Haematol; 1995 May; 90(1):216-8. PubMed ID: 7786789
[TBL] [Abstract][Full Text] [Related]
2. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome with myelofibrosis and basophilia: detection of trisomy 8 in basophils by fluorescence in-situ hybridization.
Ma SK; Chan JC; Wan TS; Chan AY; Chan LC
Leuk Lymphoma; 1998 Oct; 31(3-4):429-32. PubMed ID: 9869209
[TBL] [Abstract][Full Text] [Related]
4. A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10).
Kim M; Lim J; Lee A; Park G; Kim Y; Han K; Kang CS; Kim YJ; Song JS
Acta Haematol; 2005; 114(2):104-7. PubMed ID: 16103634
[TBL] [Abstract][Full Text] [Related]
5. Identification of Charcot-Leyden crystals by electron microscopy.
Carson HJ; Buschmann RJ; Weisz-Carrington P; Choi YS
Ultrastruct Pathol; 1992; 16(4):403-11. PubMed ID: 1502737
[TBL] [Abstract][Full Text] [Related]
6. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
[TBL] [Abstract][Full Text] [Related]
7. A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case.
Yan J; Whittom R; Delage R; Drouin R
Cancer Genet Cytogenet; 2003 Jan; 140(2):138-44. PubMed ID: 12645652
[TBL] [Abstract][Full Text] [Related]
8. Late appearance of t(1;19)(q11;q11) in myelodysplastic syndrome associated with dysplastic eosinophilia and pulmonary alveolar proteinosis.
Ando J; Tamayose K; Sugimoto K; Oshimi K
Cancer Genet Cytogenet; 2002 Nov; 139(1):14-7. PubMed ID: 12547151
[TBL] [Abstract][Full Text] [Related]
9. A case of myelodysplasia with eosinophilia having a translocation t(5;12) (q31;q13) restricted to myeloid cells but not involving eosinophils.
Jani K; Kempski HM; Reeves BR
Br J Haematol; 1994 May; 87(1):57-60. PubMed ID: 7947256
[TBL] [Abstract][Full Text] [Related]
10. Charcot-Leyden crystals in chronic eosinophilic leukemia.
Sandberg Y; Weerkamp F
Blood; 2021 Apr; 137(14):1985. PubMed ID: 33830189
[No Abstract] [Full Text] [Related]
11. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
Weller PF; Goetzl EJ; Austen KF
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
[TBL] [Abstract][Full Text] [Related]
12. Charcot-Leyden crystals: pathology and diagnostic utility.
Pantanowitz L; Balogh K
Ear Nose Throat J; 2004 Jul; 83(7):489-90. PubMed ID: 15372922
[TBL] [Abstract][Full Text] [Related]
13. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
14. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
15. Significance of Charcot Leyden crystals in liver cytology-A case report.
Thakral D; Agarwal P; Saran RK; Saluja S
Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873
[TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
Enright H; Weisdorf D; Peterson L; Rydell RE; Kaplan ME; Arthur DC
Leukemia; 1992 May; 6(5):381-4. PubMed ID: 1593903
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Leyden crystals in fine needle aspiration cytology.
Arora VK; Singh N; Bhatia A
Acta Cytol; 1997; 41(2):409-12. PubMed ID: 9100774
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ
Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562
[TBL] [Abstract][Full Text] [Related]
19. AML with inv(16) with numerous Charcot-Leyden crystals.
Dwyre DM; Osman M
Blood; 2019 Nov; 134(21):1876. PubMed ID: 31751481
[No Abstract] [Full Text] [Related]
20. Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils.
Hogge DE; Misawa S; Parsa NZ; Pollak A; Testa JR
J Clin Oncol; 1984 Jun; 2(6):550-7. PubMed ID: 6587018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
